Financial results - LAVIMAR MED SRL

Financial Summary - Lavimar Med Srl
Unique identification code: 17271080
Registration number: J22/506/2005
Nace: 4773
Sales - Ron
131.321
Net Profit - Ron
2.579
Employee
2
The most important financial indicators for the company Lavimar Med Srl - Unique Identification Number 17271080: sales in 2023 was 131.321 euro, registering a net profit of 2.579 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Lavimar Med Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 100.339 88.178 91.658 92.105 95.658 94.934 115.466 139.640 133.409 131.321
Total Income - EUR 104.678 92.090 94.563 94.484 96.160 94.934 115.466 139.766 135.592 136.216
Total Expenses - EUR 98.884 88.122 89.678 95.559 107.282 90.922 109.821 133.918 132.888 132.343
Gross Profit/Loss - EUR 5.795 3.968 4.885 -1.076 -11.122 4.012 5.645 5.848 2.703 3.873
Net Profit/Loss - EUR 4.868 3.333 4.001 -2.021 -12.039 3.189 4.521 4.571 1.431 2.579
Employees 2 2 0 2 2 2 2 2 1 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -1.3%, from 133.409 euro in the year 2022, to 131.321 euro in 2023. The Net Profit increased by 1.153 euro, from 1.431 euro in 2022, to 2.579 in the last year.

Check the financial reports for the company - Lavimar Med Srl

Rating financiar

Financial Rating -
Lavimar Med Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Lavimar Med Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Lavimar Med Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Lavimar Med Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Lavimar Med Srl - CUI 17271080

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 0 0 0 0 0 0 0 653 312
Current Assets 47.456 40.436 19.000 28.655 24.246 25.708 45.120 32.066 37.085 36.391
Inventories 21.194 28.892 8.084 11.566 3.408 6.531 14.082 3.198 5.935 11.393
Receivables 14.578 5.745 5.032 15.410 20.029 17.218 28.276 25.601 27.734 22.063
Cash 11.684 5.798 5.884 1.679 809 1.960 2.762 3.267 3.416 2.934
Shareholders Funds 1.849 5.197 9.145 6.970 -5.197 -1.907 2.651 7.163 8.616 11.169
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 45.607 35.238 9.855 21.686 29.443 27.615 42.469 24.903 29.122 25.533
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 36.391 euro in 2023 which includes Inventories of 11.393 euro, Receivables of 22.063 euro and cash availability of 2.934 euro.
The company's Equity was valued at 11.169 euro, while total Liabilities amounted to 25.533 euro. Equity increased by 2.579 euro, from 8.616 euro in 2022, to 11.169 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Lavimar Med Srl

Comments - Lavimar Med Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.